Soichi Yagi

Nishinomiya-hama, 6638501, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Initial Treatment Failure as a Predictor of Proximal Extension in Patients with Newly Diagnosed Limited Ulcerative Colitis: A Retrospective Cohort Study with Propensity Score-Matched Analysis.

Initial Treatment Failure as a Predictor of Proximal Extension in Patients with Newly Diagnosed Limited Ulcerative Colitis: A Retrospective Cohort Study with Propensity Score-Matched Analysis.

Journal: Digestive diseases and sciences

Published: October 07, 2025

Effect of Chronic Social Defeat Stress on the Small-Intestinal Environment, Including the Gut Flora, Immune System, and Mucosal Barrier Integrity.

Effect of Chronic Social Defeat Stress on the Small-Intestinal Environment, Including the Gut Flora, Immune System, and Mucosal Barrier Integrity.

Journal: International journal of molecular sciences

Published: August 05, 2025

Comparative Effectiveness of Ustekinumab and Vedolizumab as Maintenance Therapy After Tacrolimus-Induced Improvement in Patients with Acute Severe Ulcerative Colitis: A Retrospective Cohort Study.

Comparative Effectiveness of Ustekinumab and Vedolizumab as Maintenance Therapy After Tacrolimus-Induced Improvement in Patients with Acute Severe Ulcerative Colitis: A Retrospective Cohort Study.

Journal: Journal of clinical medicine

Published: June 03, 2025

Real-World Effectiveness and Safety of Mirikizumab Induction Therapy in Patients With Ulcerative Colitis: A Multicentre Retrospective Observational Study.

Real-World Effectiveness and Safety of Mirikizumab Induction Therapy in Patients With Ulcerative Colitis: A Multicentre Retrospective Observational Study.

Journal: Alimentary pharmacology & therapeutics

Published: January 23, 2025

Continuous Treatment with Tofacitinib but Not Filgotinib Is Effective in Non-Responders with Active Ulcerative Colitis: A Propensity Score-Matching Analysis.

Continuous Treatment with Tofacitinib but Not Filgotinib Is Effective in Non-Responders with Active Ulcerative Colitis: A Propensity Score-Matching Analysis.

Journal: Journal of clinical medicine

Published: November 21, 2024

Propensity score-matched real-world comparative treatment outcomes of Janus kinase inhibitors for ulcerative colitis in patients with and without prior exposure to anti-tumor necrosis factor α antibody.

Propensity score-matched real-world comparative treatment outcomes of Janus kinase inhibitors for ulcerative colitis in patients with and without prior exposure to anti-tumor necrosis factor α antibody.

Journal: Intestinal research

Published: September 22, 2024

Real-world efficacy and safety of tofacitinib treatment in Asian patients with ulcerative colitis.

Real-world efficacy and safety of tofacitinib treatment in Asian patients with ulcerative colitis.

Journal: World journal of gastroenterology

Published: January 09, 2024

Efficacy and safety of filgotinib for ulcerative colitis: A real-world multicenter retrospective study in Japan.

Efficacy and safety of filgotinib for ulcerative colitis: A real-world multicenter retrospective study in Japan.

Journal: Alimentary pharmacology & therapeutics

Published: January 02, 2024

Short-term clinical evaluation of teduglutide for patients with Crohn's disease on home parenteral support for postoperative short bowel syndrome with intestinal failure.

Short-term clinical evaluation of teduglutide for patients with Crohn's disease on home parenteral support for postoperative short bowel syndrome with intestinal failure.

Journal: Clinical nutrition (Edinburgh, Scotland)

Published: November 02, 2022

Ischemic enteritis resulting from polycythemia vera.

Ischemic enteritis resulting from polycythemia vera.

Journal: Clinical journal of gastroenterology

Published: March 08, 2022

Showing 1-10 of 10

Last Updated: 09/26/2026